Production (Stage)
E
Day One Biopharmaceuticals, Inc. DAWN
$6.67 -$0.02-0.30% NASDAQ
Recommendation
Prev Close
$6.67
Volume
1,155,808
Avg Vol (90D)
1,280,391
Market Cap
$676.09M
Dividend & Yield
--
52-Week Range
$6.08 - $16.76
P/E (TTM)
--
EPS (TTM)
-$0.6626
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bank of America Corp DE Has $260,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
6/15/2025 - MarketBeat
Day One Biopharmaceuticals (DAWN, $6.98) price exceeded its 50-day Moving Average on June 10, 2025
6/11/2025 - Tickeron - Stocks
Day One Biopharmaceuticals (DAWN) Welcomes New R&D Leader DAWN Stock News
6/10/2025 - GuruFocus
Day One Biopharmaceuticals appoints Michael Vasconcelles as Head of R&D
6/10/2025 - The Fly
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
6/10/2025 - Globe Newswire
Day One Biopharmaceuticals: Strong Ojemda Potential In Q2 And Solid Rationale For DAY-301
6/5/2025 - Seeking Alpha - Long Ideas
Day One Biopharmaceuticals: Strong Ojemda Potential In Q2 And Solid Rationale For DAY-301
6/5/2025 - SeekingAlpha
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading 9% Higher - Still a Buy?
6/3/2025 - MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by Millennium Management LLC
6/2/2025 - MarketBeat
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Down 4.9% - Should You Sell?
5/31/2025 - MarketBeat
Day One Biopharmaceuticals (DAWN, $6.48) entered Uptrend as Momentum indicator ascends above 0 level on May 29, 2025
5/30/2025 - Tickeron - Technical Analysis
Day One Biopharmaceuticals (DAWN, $6.27) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 23, 2025
5/24/2025 - Tickeron - Stocks
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of "Buy" from Brokerages
5/24/2025 - MarketBeat
We Did The Math VTWO Can Go To $108
5/22/2025 - ETF Channel
Insider Selling: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CFO Sells $26,805.32 in Stock
5/22/2025 - Ticker Report
Vestal Point Capital LP Sells 1,060,000 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/21/2025 - MarketBeat
Rafferty Asset Management LLC Raises Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/21/2025 - Ticker Report
Tema Etfs LLC Invests $1.09 Million in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/20/2025 - MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) General Counsel Adam Dubow Sells 4,552 Shares
5/20/2025 - Ticker Report
Jeremy Bender Sells 13,964 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stock
5/20/2025 - MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Insider Lauren Merendino Sells 3,927 Shares
5/19/2025 - Ticker Report
Tema Etfs LLC Acquires New Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/18/2025 - Ticker Report
Janus Henderson Group PLC Reduces Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/18/2025 - MarketBeat
Balyasny Asset Management L.P. Purchases New Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/17/2025 - Ticker Report
Parkwood LLC Takes $3.48 Million Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
5/16/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$161.92M
EBITDA (TTM)
-$189.21M
EBIT (TTM)
-$191.57M
Net Income (TTM)
-$69.08M
Balance Sheet
Total Assets (Q)
$534.36M
Total Debt (Q)
$2.92M
Total Liabilities (Q)
$54.84M
Book Value Per Share (Q)
$4.73
Cash Flow
Cash from Operations (TTM)
-$87.38M
Cash from Investing (TTM)
-$352.90M
Cash from Financing (TTM)
$203.24M
Net Change in Cash (TTM)
-$237.03M
Filings
Filing Date
Tuesday, May 6, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Loading...
Beta
1.18
7-Day Total Return
-4.03%
30-Day Total Return
-15.89%
60-Day Total Return
-19.93%
90-Day Total Return
-45.42%
Year to Date Total Return
-47.52%
1-Year Total Return
-47.11%
2-Year Total Return
-50.48%
3-Year Total Return
-57.86%
5-Year Total Return
--
52-week Low
May 15, 2025 - $6.08
52-week High
Nov 08, 2024 - $16.76
Valuation
Market Cap
$676.09M - Small Cap
Enterprise Value
$205.98M
Price/Sales (TTM)
4.23
Price/Book (Q)
1.41
Dividends and Shares
Shares Outstanding
102.71M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
dayonebio.com
Phone Number
650 484 0899
Address
1800 Sierra Point Parkway
Brisbane, CA 94005
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company’s lead... more
NASDAQ 06/13/2025 4:00PM Eastern Quotes delayed